Aspergillus fumigatus-derived demethoxyfumitremorgin C inhibits proliferation of PC3 human prostate cancer cells through p53/p21-dependent G1 arrest and apoptosis induction
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Human prostate cancer is the second most frequently diagnosed cancer worldwide, and its incidence rate continues to increase. Advanced prostate cancer is more difficult to treat than early forms due to its chemotherapy resistance. There is need for more effective agents that can inhibit the progression of advanced prostate cancer. Demethoxyfumitremorgin C (DMFTC) was isolated from the fermentation extract of the marine fungus Aspergillus fumigatus. Antiproliferative activity of DMFTC against human prostate cancer PC3 cells was examined through cell cycle analysis by flow cytometry, the fluorescent nuclear imaging analysis with propidium iodide (PI), and proteins expression related to cell cycle arrest and apoptosis were investigated via Western blotting. DMFTC inhibited PC3 cells growth through G1 phase cell cycle arrest and apoptosis induction. It activated the tumor suppressor p53 and the Cdk inhibitor p21, which regulate the cell progression into the G1 phase. Additionally, PI-positive late apoptotic non-viable cells were increased and the expression levels of the G1-positive downstream regulators cyclin D, cyclin E, Cdk2, and Cdk4 were decreased by DMFTC treatment. These results suggest that DMFTC induces G1 arrest and apoptosis induction through regulation of p53/p21-dependent cyclin-Cdk complexes, and it may be a useful therapeutic agent for the treatment of human advanced prostate cancer.
Abstract
Human prostate cancer is the second most frequently diagnosed cancer worldwide, and its incidence rate continues to increase. Advanced prostate cancer is more difficult to treat than early forms due to its chemotherapy resistance. There is need for more effective agents that can inhibit the progression of advanced prostate cancer. Demethoxyfumitremorgin C (DMFTC) was isolated from the fermentation extract of the marine fungus Aspergillus fumigatus. Antiproliferative activity of DMFTC against human prostate cancer PC3 cells was examined through cell cycle analysis by flow cytometry, the fluorescent nuclear imaging analysis with propidium iodide (PI), and proteins expression related to cell cycle arrest and apoptosis were investigated via Western blotting. DMFTC inhibited PC3 cells growth through G1 phase cell cycle arrest and apoptosis induction. It activated the tumor suppressor p53 and the Cdk inhibitor p21, which regulate the cell progression into the G1 phase. Additionally, PI-positive late apoptotic non-viable cells were increased and the expression levels of the G1-positive downstream regulators cyclin D, cyclin E, Cdk2, and Cdk4 were decreased by DMFTC treatment. These results suggest that DMFTC induces G1 arrest and apoptosis induction through regulation of p53/p21-dependent cyclin-Cdk complexes, and it may be a useful therapeutic agent for the treatment of human advanced prostate cancer.
참고문헌 (26)
- Baade PD, "International epidemiology of prostate cancer : geographical distribution and secular trends", Mol Nutr Food Res, 53, pp.171~184 (2009)
- Ben-Ami R, "Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites", Blood, 114, pp.5393~5399 (2009)
- Bykov VJ, "Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound", Nat Med, 8, pp.282~288 (2002)
- Clarke AR, "Thymocyte apoptosis induced by p53-dependent and independent pathways", Nature, 362, pp.849~852 (1993)
- Cory S, "The Bcl-2 family : roles in cell survival and oncogenesis", Oncogene, 22, pp.8590~8607 (2003)
- Cui CB, "Novel mammalian cell cycle inhibitors, tryprostatins A, B and other diketopiperazines produced by Aspergillus fumigatus. I. taxonomy, fermentation, isolation and biological properties", J Antibiot, 49, pp.527~533 (1996)
- Cui CB, "Novel mammalian cell cycle inhibitors, cyclotroprostatins A–D, produced by Aspergillus fumigatus, which inhibit mammalian cell cycle at G2", M phase, 1997, pp.53, 59~72
- Cuzick J, "Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer : a retrospective study", Lancet Oncol, 12, pp.245~255 (2011)
- Di Leonardo A, "DNA damage triggers a prolonged p53-dependent G1 arrest and longterm induction of Cip1 in normal human fibroblasts", Genes Dev, 8, pp.2540~2551 (1994)
- diazaoctane ring system of prenylated indole alkaloids, "J Nat Prod", 2012, 812~833
- Gupta S, "Molecular pathway for(–)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells", Arch Biochem Biophys, 410, pp.177~185 (2003)
- Hussain M, "Intermittent versus continuous androgen deprivation in prostate cancer", N Engl J Med, 368, pp.1314~1325 (2013)
- Karnak D, "Chemosensitization of prostate cancer by modulating Bcl-2 family proteins", Curr Drug Targets, 11, pp.699~707 (2010)
- Killough JH, "The treatment of amebiasis with fumagillin", Science, 115, pp.71~72 (1952)
- Kim YS, "Apoptotic effect of demethoxyfumitremorgin C from marine fungus Aspergillus fumigatus on PC3 human prostate cancer cells", Chem Biol Interact, 269, pp.18~24 (2017)
- Kyprianou N, "Apoptotic versus proliferative activities in human benign prostatic hyperplasia", Hum Pathol, 27, pp.668~675 (1996)
- Lee DH, "Role of Bax in quercetin-induced apoptosis in human prostate cancer cells", Biochem Pharmacol, 75, pp.2345~2355 (2008)
- Li YX, "In vitro induction of apoptosis by isosclerone from marine-derived fungus Aspergillus fumigatus", Bioorg Med Chem Lett, 24, pp.3923~3927 (2014)
- Livingstone LR, "Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53", Cell, 70, pp.923~935 (1992)
- Molina JM, "Fumagillin treatment of intestinal microsporidiosis", N Engl J Med, 346, pp.1963~1969 (2002)
- Naito Y, "CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer", Cancer Res, 58, pp.3491~3494 (1998)
- Pilat MJ, "Hormone resistance in prostate cancer", Cancer Metastasis Rev, 17, pp.373~381 (1998)
- Quinn M, "Patterns and trends in prostate cancer incidence, survival, prevalence and mortality", Part I : international comparisons, 90, pp.162~173 (2002)
- Sherr CJ, "Cancer cell cycles", Science, 274, pp.1672~1677 (1996)
- Swathi J, "Marine fungal metabolites as a rich source of bioactive compounds", African J Biochem Res, 7, pp.184~196 (2013)
- Yin XY, "C-myc overexpression and p53 loss cooperate to promote genomic instability", Oncogene, 18, pp.1177~1184 (1999)